PM asks CMs to address challenge of TB in mission mode

Image
Press Trust of India New Delhi
Last Updated : Jan 21 2018 | 10:55 AM IST
Prime Minister Narendra Modi has written to all chief ministers, asking them address the challenge of tuberculosis in a mission mode and review the progress of the Revised National Tuberculosis Control Programme (RNTCP) at least every quarter.
He urged them to closely monitor key performance indicators such as case notification (including from private sector), treatment success rate and active case finding.
He said tuberculosis is the biggest killer among all infectious diseases and about 29 lakh new TB cases are reported every year.
About 4.20 lakh people, mostly poor, die annually due to tuberculosis, leaving lakhs of children orphaned. Economic loss on account of TB in India is about Rs 20,000 crore per annum, Modi wrote in the letter.
"We cannot allow such human tragedies, for a disease which is treatable and for which drugs and diagnostics are available in the public health care system," the letter read.
The PM wrote the government was committed to eliminating TB by 2015, five years ahead of the Sustainable Development Goals for which the health ministry was implementing the RNTCP with "new vigour".
The RNTCP has taken several new initiatives like daily regimen, universal drug susceptibility testing, active case finding in vulnerable groups and cross reference between HIV and TB cases to help us address the challenge posed by TB, he wrote.
"It is incumbent upon us to address this challenge in a mission mode. I request you to kindly reveiw the progress of the programme at least every quarter and closely monitor key performance indicators like case notification (including from private sector), treatment success rate, active case finding and HR vacancy," he said.
The government is planning to give Rs 500 a month to tuberculosis patients, irrespective of their income level, to help them buy nutritious food and compensate them for travel expenses until they are cured.
The Expenditure Finance Committee has approved the proposal and sent it to the Mission Steering Group, a health ministry official had said earlier.
The ministry recently rolled out the daily drug regimen to combat the disease across the country.
Under the new treatment policy, patients are given fixed drug combinations - three or four drugs in a single pill - daily, instead of thrice a week (intermittent drug regimen).
Dosage is determined according to the patient's body weight. Previously, it was same for all adults.
Also, children suffering from tuberculosis won't have to take the bitter tablets anymore as they will be replaced with easily-dissoluble and flavoured drugs.
Since 1997, under the RNTCP, patients were being administered drugs thrice a week. The daily treatment regimen is likely to be more effective with lesser relapses and it is expected to reduce drug-resistance with greater compliance.
The WHO revised its TB management guidelines in 2010, recommending that the daily drug regimen be adopted under the RNTCP.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 21 2018 | 10:55 AM IST

Next Story